- Home
- TDW vs VKTX Comparison
TDW vs VKTX Comparison
Compare TDW & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TDW
- VKTX
- Stock Information
- Founded
- TDW 1956
- VKTX 2012
- Country
- TDW United States
- VKTX United States
- Employees
- TDW N/A
- VKTX N/A
- Industry
- TDW Marine Transportation
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- TDW Consumer Discretionary
- VKTX Health Care
- Exchange
- TDW Nasdaq
- VKTX Nasdaq
- Market Cap
- TDW 2.4B
- VKTX 2.8B
- IPO Year
- TDW N/A
- VKTX 2015
- Fundamental
- Price
- TDW $51.46
- VKTX $30.40
- Analyst Decision
- TDW Buy
- VKTX Buy
- Analyst Count
- TDW 2
- VKTX 12
- Target Price
- TDW $69.00
- VKTX $84.00
- AVG Volume (30 Days)
- TDW 983.8K
- VKTX 4.1M
- Earning Date
- TDW 08-05-2025
- VKTX 07-23-2025
- Dividend Yield
- TDW N/A
- VKTX N/A
- EPS Growth
- TDW 32.96
- VKTX N/A
- EPS
- TDW 3.34
- VKTX N/A
- Revenue
- TDW $1,358,115,000.00
- VKTX N/A
- Revenue This Year
- TDW $0.68
- VKTX N/A
- Revenue Next Year
- TDW $6.20
- VKTX N/A
- P/E Ratio
- TDW $15.39
- VKTX N/A
- Revenue Growth
- TDW 19.34
- VKTX N/A
- 52 Week Low
- TDW $31.17
- VKTX $18.92
- 52 Week High
- TDW $108.44
- VKTX $81.73
- Technical
- Relative Strength Index (RSI)
- TDW 73.04
- VKTX 62.76
- Support Level
- TDW $47.00
- VKTX $27.10
- Resistance Level
- TDW $48.84
- VKTX $28.80
- Average True Range (ATR)
- TDW 1.82
- VKTX 1.73
- MACD
- TDW 0.31
- VKTX 0.38
- Stochastic Oscillator
- TDW 88.42
- VKTX 85.49
About TDW Tidewater Inc.
Tidewater Inc provides marine and transportation services to the offshore energy industry. The company's vessels and associated services support all phases of offshore crude oil and natural gas (also referred to as oil and gas) exploration activities, field development, production, and maintenance, as well as windfarm development and maintenance. Its services include towing and anchor handling for mobile offshore drilling units; transporting supplies and personnel necessary to sustain drilling, workovers, production activities, field abandonment, dismantlement, and restoration activities; and Others. The group manages its business through five segments including the Americas, Asia Pacific, Middle East, Europe/Mediterranean, and West Africa.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.